Angelini Chemicals

News & publications

  1. Pubblicato:

    HIGH-POTENT API: Strategy and Legacy

    The pharmaceutical landscape is continuously evolving, driven by innovation in drug development and the growing demand for targeted therapies. High-potency active pharmaceutical ingredients (HPAPIs) have emerged as crucial components in treating diseases such as cancer and autoimmune disorders. Recognizing the increasing importance of HPAPIs, our company has strategically diversified into their production, and our extensive experience in producing traditional APIs provides a foundation for success in this new venture.

Who we are

  1. What we do

    Since 1967, branded and generic pharmaceutical industries have been relying on Angelini Fine Chemicals to accelerate their R&D portfolio to the pharmaceutical market.

  2. Our plant

    With over 50 years of experience in pharmaceuticals manufacturing industry, Angelini Fine Chemicals is one of the major API manufacturers in Italy and Europe.

Our services

R&D

  1. API expertise

    Angelini’s strength in API Research & Development is proven by being the partner of choice for large pharma and smaller biotech companies seeking integrated drug development solutions to accelerate R&D pipelines from bench to market.
  2. Kilo-lab

    Angelini R&D team can rapidly develop scalable, robust and cost-effective chemical synthesis that can be readily transferred to our kilo-labs either as a proof of concept study, or for scale-up and delivery of material to support your early clinical supply as well as small volume API and HPAPI.
  3. Reaction Technology

    Angelini Fine Chemicals has a long tradition in API industry and has built up a comprehensive capability and expertise to carry out complex and hazardous operations for the manufacturing API and HPAPI, safely, in accordance with cGMP standards and customer quality expectations.